Effect of Titania Concentration in Bioglass/TiO₂ Nanostructures and Its In Vitro Biological Property Assessment

Bioglass 45S5 (45% SiO2-24.5% NaO-24.5% CaO-6% P2O5) is a unique bioactive material, which is being used for bone and dental substitution. This system has been highly preferred for its osteoconductive and osteoinductive performance. Despite its attractive bioactivity, there are limitations in using this material for orthopedic and dental applications due to its poor processability and mechanical strength. To improve the load-sharing and stress distribution, TiO2 nanoparticles have been introduced into the nanoBioglass (nBG) by sol-gel method. The structural analyses of the samples were confirmed using X-ray diffraction, Raman-spectroscopy and FTIR. The morphologies of the samples were characterized by FESEM. The apatite formation of the nBG/TiO2 composites was investigated by immersing the samples in simulated body Fluid (SBF) solution for 1 and 3 days, which reveals the acceptable compatibility for different concentrations of all the composition. Hemolysis studies of the nanobiomaterials were carried out to understand the interactions of biomaterials with blood which shows 0.2%-2% of lysis which is acceptable as per ASTM standard. Cell culture and cell proliferation studies of bioglass, nBG/TiO2 nanocomposite on MG-63 pre-osteoblast cell line for 24 h, 48 h and 72 h showed 80% to 95% of cell viability. Also, it was found that the nBG/TiO2 bio-nanocomposites containing low content of titania had good bioactivity properties that is comparable to cortical bone. Hence, nBG/TiO2 bio-nanocomposites are greatly promising for medical applications such as bone substitutes especially in load-bearing sites.